Jolanta Bondaruk

43.4k total citations · 1 hit paper
23 papers, 2.7k citations indexed

About

Jolanta Bondaruk is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Jolanta Bondaruk has authored 23 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 14 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Jolanta Bondaruk's work include Bladder and Urothelial Cancer Treatments (16 papers), Epigenetics and DNA Methylation (11 papers) and Urinary and Genital Oncology Studies (7 papers). Jolanta Bondaruk is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Epigenetics and DNA Methylation (11 papers) and Urinary and Genital Oncology Studies (7 papers). Jolanta Bondaruk collaborates with scholars based in United States, Canada and Japan. Jolanta Bondaruk's co-authors include Bogdan Czerniak, Colin P. Dinney, David J. McConkey, Keith Baggerly, Tadeusz Majewski, Arlene O. Siefker‐Radtke, Shizhen Zhang, Woonyoung Choi, Shanna Pretzsch and Seungchan Kim and has published in prestigious journals such as Nature Genetics, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jolanta Bondaruk

22 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

2014 1.2k citations Woonyoung Choi, Sima P. Porten et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jolanta Bondaruk United States	17	1.8k	1.3k	838	607	386	23	2.7k
Kristina Lövgren Sweden	22	1.2k 0.7×	1.2k 0.9×	1.0k 1.2×	565 0.9×	110 0.3×	32	2.5k
Abdel Saci United States	16	1.3k 0.8×	802 0.6×	2.1k 2.5×	756 1.2×	173 0.4×	32	3.2k
Catherine Mazerolles France	22	635 0.4×	517 0.4×	276 0.3×	195 0.3×	211 0.5×	59	1.4k
Philipp Erben Germany	32	699 0.4×	830 0.7×	640 0.8×	468 0.8×	59 0.2×	161	3.8k
Abha Khanna United States	12	504 0.3×	764 0.6×	761 0.9×	352 0.6×	51 0.1×	28	1.8k
Maria Giulia Cangi Italy	21	303 0.2×	914 0.7×	878 1.0×	479 0.8×	257 0.7×	55	2.2k
P Cairns United States	17	496 0.3×	1.7k 1.4×	599 0.7×	629 1.0×	114 0.3×	18	2.5k
Colin Marsh United Kingdom	13	271 0.2×	732 0.6×	675 0.8×	542 0.9×	106 0.3×	18	1.5k
Jon Chung United States	25	424 0.2×	765 0.6×	1.0k 1.2×	720 1.2×	64 0.2×	109	2.0k
Cristina Cruz Spain	15	634 0.4×	922 0.7×	2.8k 3.3×	657 1.1×	91 0.2×	36	3.7k

Countries citing papers authored by Jolanta Bondaruk

Since Specialization

Citations

This map shows the geographic impact of Jolanta Bondaruk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanta Bondaruk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanta Bondaruk more than expected).

Fields of papers citing papers by Jolanta Bondaruk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolanta Bondaruk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanta Bondaruk. The network helps show where Jolanta Bondaruk may publish in the future.

Co-authorship network of co-authors of Jolanta Bondaruk

This figure shows the co-authorship network connecting the top 25 collaborators of Jolanta Bondaruk. A scholar is included among the top collaborators of Jolanta Bondaruk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolanta Bondaruk. Jolanta Bondaruk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herling, Carmen, Kevin R. Coombes, Axel Benner, et al.. (2019). Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study. The Lancet Oncology. 20(11). 1576–1586. 15 indexed citations

Zhang, Shizhen, Yan Wang, Jolanta Bondaruk, et al.. (2018). Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test. European Urology Focus. 5(4). 664–675. 4 indexed citations

Zhang, Miao, Adebowale Adeniran, Raghunandan Vikram, et al.. (2017). Carcinoma of the urethra. Human Pathology. 72. 35–44. 26 indexed citations

Guo, Charles C., Vipulkumar Dadhania, Li Zhang, et al.. (2016). Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer. European Urology. 70(4). 611–620. 121 indexed citations

Dadhania, Vipulkumar, Miao Zhang, Li Zhang, et al.. (2016). Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use. EBioMedicine. 12. 105–117. 248 indexed citations

Oshiro, Hisashi, Bogdan Czerniak, Kentaro Sakamaki, et al.. (2016). Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer. Medicine. 95(31). e4500–e4500. 2 indexed citations

Choi, Woonyoung, Sima P. Porten, Seungchan Kim, et al.. (2014). Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy. Cancer Cell. 25(2). 152–165. 1185 indexed citations breakdown →

Chung, Woonbok, Jolanta Bondaruk, Nianxiang Zhang, et al.. (2012). Abstract 5004: CpG island methylator phenotype in bladder cancer. Cancer Research. 72(8_Supplement). 5004–5004.

Majewski, Tadeusz, Philippe E. Spiess, Jolanta Bondaruk, et al.. (2012). Detection of Bladder Cancer Using Proteomic Profiling of Urine Sediments. PLoS ONE. 7(8). e42452–e42452. 8 indexed citations

10.

Akli, Saïd, et al.. (2012). Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer. Cell Cycle. 11(7). 1468–1476. 19 indexed citations

11.

Chung, Woonbok, Jolanta Bondaruk, Jaroslav Jelı́nek, et al.. (2011). Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments. Cancer Epidemiology Biomarkers & Prevention. 20(7). 1483–1491. 127 indexed citations

12.

Dancer, Jane, Stephen P. Henry, Jolanta Bondaruk, et al.. (2010). Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors. Human Pathology. 41(12). 1788–1793. 24 indexed citations

13.

Guo, Charles C., Enrique Gómez‐Gómez, Pheroze Tamboli, et al.. (2009). Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Human Pathology. 40(10). 1448–1452. 39 indexed citations

14.

Park, Hong Seok, Weon Seo Park, Jolanta Bondaruk, et al.. (2008). Quantitation of Aurora Kinase A Gene Copy Number in Urine Sediments and Bladder Cancer Detection. JNCI Journal of the National Cancer Institute. 100(19). 1401–1411. 58 indexed citations

15.

Kassouf, Wassim, Peter C. Black, Tomasz Tuziak, et al.. (2007). Distinctive Expression Pattern of ErbB Family Receptors Signifies an Aggressive Variant of Bladder Cancer. The Journal of Urology. 179(1). 353–358. 78 indexed citations

16.

Spiess, Philippe E., Jolanta Bondaruk, Melanie Dujka, et al.. (2006). Mutations Within the Kinase Domain and Truncations of the Epidermal Growth Factor Receptor Are Rare Events in Bladder Cancer: Implications for Therapy. Clinical Cancer Research. 12(15). 4671–4677. 53 indexed citations

17.

Tuziak, Tomasz, Limei Hu, Zhi Wang, et al.. (2005). Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. Laboratory Investigation. 85(4). 532–549. 37 indexed citations

18.

Shao, Lina, Jolanta Bondaruk, Bogdan Czerniak, et al.. (2004). Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes and Cancer. 41(4). 379–389. 3 indexed citations

19.

Sathyanarayana, Ubaradka G., Riichiroh Maruyama, Asha Padar, et al.. (2004). Molecular Detection of Noninvasive and Invasive Bladder Tumor Tissues and Exfoliated Cells by Aberrant Promoter Methylation of Laminin-5 Encoding Genes. Cancer Research. 64(4). 1425–1430. 71 indexed citations

20.

Katayama, Hiroshi, Kaori Sasai, Hidehiko Kawai, et al.. (2003). Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genetics. 36(1). 55–62. 495 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact